Thermo Fisher Scientific Appoints Srinath Venkatesh as MD for India & South Asia

Venkatesh, envisions advancing Thermo Fisher's growth and operations in India while enhancing customer value creation.

Thermo Fisher Scientific, the world leader in serving science, has appointed Srinath Venkatesh as Managing Director, India and South Asia, for the company.

With this new role and responsibility, Venkatesh, the new MD envisions advancing Thermo Fisher's growth and operations in India, while enhancing customer value creation.

On the appointment, Tony Acciarito, president, Asia Pacific and Japan, Thermo Fisher Scientific said, “India’s resilient economy has a high growth trajectory and highlights the significance of a progressive approach, despite signs of a global economic slowdown. With an industry-leading presence in the country, Thermo Fisher Scientific is well-positioned to contribute to priority sectors such as healthcare, pharma and biopharma, renewable energy and semiconductor manufacturing.”

Srinath further emphasised Venkatesh’s experience of over 30 years in driving commercial excellence across industrial and capital businesses. which according to him, will be instrumental in leveraging the company’s scale in high-growth and emerging markets.

Further, he noted that this move will also help elevate the company’s impact in India’s evolving landscape.

Prior to joining Thermo Fisher, he served as the president, Danaher for their India operations. In his previous roles, he has held several positions including MD - India & SEA for Cepheid and DBS Leader for Danaher Corporation.

Moreover, he has also held significant business leadership positions at GE Capital and GE Lighting including Country leader and CEO of GE Bangladesh.

Expressing thoughts, Srinath Venkatesh said, “India’s vast addressable market presents attractive opportunities. With its scale and depth of capabilities, accelerated investments in innovation and a focus on expanding its localisation strategy, Thermo Fisher is contributing to the country’s scientific and technological progress. I am looking forward to collaborating closely with the diverse and talented team of over 4700 colleagues across the country to enable our customers’ success.”

Reportedly, Venkatesh’s proven track record in business expansion and focus on technology and innovation is expected to drive Thermo Fisher toward the next phase of robust and sustained growth.

Thermo Fisher’s Healthcare Offerings

Since 1996, when Thermo Fisher established its operations in India, the company has strengthened its presence with eight manufacturing facilities, five application labs, two R&D centres, and eight distribution centres, supported by an extensive network of 400-plus channel partners, and approximately 4,700 employees (including PPD) strategically located in 42 cities and offices across 17 locations.

Going forward, Thermo Fisher Scientific plans to launch ‘Lab of the Future’. This involves building an integrated ecosystem between analytical instruments, software, and data. The company aims to automate and connect instruments, overcome people, process, and technology hurdles, and enable businesses to continuously innovate.

Last year, Thermo Fisher Scientific and Pfizer entered into a collaboration agreement to help increase local access to next-generation sequencing (NGS)-based testing for lung and breast cancer patients in more than 30 countries across Latin America, Africa, the Middle East, and Asia.

With an annual revenue of more than $40 billion, Thermo Fisher Scientific Inc. is an American supplier of analytical instruments, life sciences solutions, speciality diagnostics, laboratory, pharmaceutical, and biotechnology services. Their products and services are designed to address a range of needs from sample, material characterisation, and chemical analysis to clinical diagnoses and biological-based therapeutics manufacturing. The company aims to enable its customers to make the world healthier, cleaner and safer.